2013
DOI: 10.1016/j.ejogrb.2013.02.008
|View full text |Cite
|
Sign up to set email alerts
|

Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
27
0
1

Year Published

2014
2014
2017
2017

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(28 citation statements)
references
References 19 publications
0
27
0
1
Order By: Relevance
“…HSG was performed in all patients and confirmed tubal occlusion in all but 1 patient with a monolateral hydrosalpinx who was eligible for in vitro fertilization, and a tubal dilatation was likely the reason for the tubal occlusion [17][18][19]. The position of this device was unsatisfactory at 2DUS according to the classification of Veersema, and inadequate at 3DUS according to the Legendre classification.…”
Section: Resultsmentioning
confidence: 88%
See 1 more Smart Citation
“…HSG was performed in all patients and confirmed tubal occlusion in all but 1 patient with a monolateral hydrosalpinx who was eligible for in vitro fertilization, and a tubal dilatation was likely the reason for the tubal occlusion [17][18][19]. The position of this device was unsatisfactory at 2DUS according to the classification of Veersema, and inadequate at 3DUS according to the Legendre classification.…”
Section: Resultsmentioning
confidence: 88%
“…Use of Essure microinserts for therapeutic purposes (e.g., presence of hydrosalpinx or sactosalpinx) is largely supported by international literature and advocated by scientific societies as a safe, effective, and minimally invasive alternative to salpingectomy, whereas laparoscopic treatment is contraindicated [17][18][19][22][23][24][25].…”
Section: Discussionmentioning
confidence: 99%
“…Nonetheless their efficacy remains unproved, due to the small number of studies, often retrospective and small. Placement of Essure 1 microinserts before ART is currently the alternative that has shown best results, since seven studies have been reported, all concluding favourably [11][12][13][14][15][16][17]. Transvaginal aspiration of the hydrosalpinx on the day of the oocyte retrieval remains a controversial option because the fluid accumulation is known to reconstitute within several hours [23].…”
Section: Population Of Women With Transfersmentioning
confidence: 99%
“…The surgical risk during laparoscopy, especially for women with major pelvic adhesions, has led some surgeons to use Essure 1 for hysteroscopic tubal occlusion, an off-label use different from its primary purpose of tubal sterilisation. Currently, seven small studies [11][12][13][14], including prospective randomised trials [15,16] and a controlled study [17], have produced fairly positive results. We sought to assess the feasibility and short-and intermediateterm results of this practice in a nationwide enquiry.…”
mentioning
confidence: 99%
“…В литературе представлены исследования, опи-сывающие отрицательное воздействие СЭ на овари-альный резерв [9][10][11][12][13][14][15][16], косвенные доказательства снижения функции яичников [17] и данные об от-сутствии влияния операции на женские гонады [8,[18][19][20][21][22].…”
unclassified